Pharmaceutical

Filter

Current filters:

None

Popular Filters

1 to 25 of 7024 results

Vifor appoints Dario Eklund head of international business and Abdul Mullick head of global marketing

Vifor appoints Dario Eklund head of international business and Abdul Mullick head of global marketing

19-09-2014

Swiss-based iron deficiency specialist Vifor Pharma has appointed Dario Eklund as head of international…

BoardroomHematologyPharmaceuticalSwitzerlandVifor Pharma

EXPERT VIEW: The Interim Exec Community calls for a ‘Conscious Coupling’ of RPOs and Interims Specialists

EXPERT VIEW: The Interim Exec Community calls for a ‘Conscious Coupling’ of RPOs and Interims Specialists

19-09-2014

Pharmaceutical companies have widely adopted strategies to outsource elements of their business operations,…

BoardroomGlobalInterviewsPharmaceuticalRecruitment

Report shows Eylea and Lucentis are equally likely to be covered by payers

Report shows Eylea and Lucentis are equally likely to be covered by payers

19-09-2014

Recently launched anti-vascular endothelial growth factor (VEGF) agent Eylea (aflibercept), from USA-based…

EyleaFinancialGenentechLucentisOphthalmicsPharmaceuticalRegeneron PharmaceuticalsUSA

Spain's pharma community has made necessary adjustments in recession, says PharmaBoardroom report

Spain's pharma community has made necessary adjustments in recession, says PharmaBoardroom report

19-09-2014

The Spanish pharma community has remained pragmatic throughout the European recession, says PharmaBoardroom’s…

Health Medical PharmaLife Sciences ReviewMarkets & MarketingPharmaceuticalSpain

EASD 2014: Novo Nordisk updates on Ryzodeg, Tresiba and Xultophy

EASD 2014: Novo Nordisk updates on Ryzodeg, Tresiba and Xultophy

19-09-2014

The global burden of diabetes is growing fast with an astonishing 10% of global healthcare expense spent…

DenmarkDiabetesEuropeMexicoNovo NordiskPharmaceuticalResearchRyzodegTresibaXultophy

GlaxoSmithKline fined $480 million over China bribery issues

GlaxoSmithKline fined $480 million over China bribery issues

19-09-2014

UK pharma giant GlaxoSmithKline today announced that the Changsha Intermediate People’s Court in Hunan…

ChinaFinancialGlaxoSmithKlineLegalPharmaceutical

Vivus and Auxilium’s Stendra ED drug approved as “on-demand” treatment in USA

Vivus and Auxilium’s Stendra ED drug approved as “on-demand” treatment in USA

19-09-2014

The US Food and Drug Administration has approved a supplemental New Drug Application for Stendra (avanafil),…

Auxilium PharmaceuticalsMen's HealthPharmaceuticalRegulationStendraUSAVivus

EyeForPharma Multichannel Marketing Summit 2014: Lundbeck's Tim White on customer interaction, apps and buzzwords

EyeForPharma Multichannel Marketing Summit 2014: Lundbeck's Tim White on customer interaction, apps and buzzwords

19-09-2014

Tim White is head of global customer interaction at Lundbeck. The Pharma Letter spoke to him at the EyeForPharma…

DenmarkLundbeckMarkets & MarketingNeurologicalPharmaceutical

First domestic-made erectile dysfunction drug debuts in China

19-09-2014

A Chinese pharmaceutical company on Thursday launched the country's first domestic-made erectile dysfunction…

Bai Yun Shan PharmaceuticalChinaJingeMarkets & MarketingMen's HealthPharmaceutical

FDA approves Lilly’s Trulicity to treat type 2 diabetes

FDA approves Lilly’s Trulicity to treat type 2 diabetes

19-09-2014

The US Food and Drug Administration yesterday approved pharma major Eli Lilly’s Trulicity (dulaglutide),…

BydureonDiabetesdulaglutideEli LillyPharmaceuticalRegulationTanzeumTrulicityUSAVictoza

Merck KGaA promotes pharma CEO Stefan Oschmann to deputy CEO

Merck KGaA promotes pharma CEO Stefan Oschmann to deputy CEO

18-09-2014

The board of partners of Germany’s Merck KGaA has promoted Stefan Oschmann to the position of deputy…

BoardroomGermanyMerck KGaAPharmaceuticalStefan Oschmann

NICE and ABPI call for reform of drug appraisals after consultation

NICE and ABPI call for reform of drug appraisals after consultation

18-09-2014

The UK’s Association of the British Pharmaceutical Industry (ABPI) has called for a “more ambitious…

Care ExcellenceHealthcareNHSPharmaceuticalUK

Biogen and AbbVie report reduced disease activity with MS drug Zinbryta

Biogen and AbbVie report reduced disease activity with MS drug Zinbryta

18-09-2014

US biotech company Biogen Idec and US pharma giant AbbVie have announced the full results from the Phase…

AbbVieAvonexBiogen IdecImmune systemMultiple sclerosisNeurologicalPharmaceuticalResearchUSAZinbryta

Bayer plans to focus entirely on Life Science businesses

Bayer plans to focus entirely on Life Science businesses

18-09-2014

The board of management of Germany’s Bayer AG plans to focus the Bayer Group entirely on the Life Science…

BayerFinancialGermanyManagementPharmaceutical

Merck Serono on track with pharma strategy

Merck Serono on track with pharma strategy

18-09-2014

Germany’s Merck KGaA says that its biopharmaceutical division - Merck Serono - is well on track with…

ataciceptBiosimilarsFinancialGermanyImmunologicalsMerck KGaAMerck SeronoOncologyPharmaceuticalResearchTH-302

Disparity between investment reports as Canada’s Rx&D warns of “serious challenges”

Disparity between investment reports as Canada’s Rx&D warns of “serious challenges”

18-09-2014

Canada’s trade group Research-Based Pharmaceutical Companies (Rx&D) has acknowledged that the environment…

CanadaFinancialPharmaceuticalResearchRx&D

First Ph III data in Japanese patients for Merck’s omarigliptin for type 2 diabetes

18-09-2014

US pharma giant Merck & Co has announced the presentation of the first data from the Phase III clinical…

DiabetesJapanMerck & CoomarigliptinPharmaceuticalRegulationResearch

Opportunity for emerging agents in Crohn’s disease, report finds

Opportunity for emerging agents in Crohn’s disease, report finds

18-09-2014

New research from Decision Resources Group has found that only a small proportion of patients with Crohn's…

Anti-Arthritics/RheumaticsBiosimilarsEntyvioHumiraPharmaceuticalRemicadeResearchStelaraUSAXeljanz

AACR report calls for US cancer funding to be a national priority

AACR report calls for US cancer funding to be a national priority

18-09-2014

Declining budgets have slowed the pace of research into cancer, according to a new report from the American…

AbraxaneCyramzaFinancialGazyvaImbruvicaNexavarOncologyPharmaceuticalResearchTafinlarUSAZydelig

UK NICE consults on draft guidance for hepatitis C drug Olysio

UK NICE consults on draft guidance for hepatitis C drug Olysio

18-09-2014

In draft guidance published today UK drugs watchdog the National Institute for Health and Care Excellence…

Anti-viralsJanssenJohnson & JohnsonOlysioPharmaceuticalPricingRegulationUK

UK’s NICE proposes to recommend GSK’s Tafinlar for melanoma

UK’s NICE proposes to recommend GSK’s Tafinlar for melanoma

18-09-2014

UK drugs watchdog the National Institute for Health and Care Excellence (NICE) has issued final draft…

GlaxoSmithKlineOncologyPharmaceuticalPricingRegulationRocheTafinlarUKZelboraf

1 to 25 of 7024 results

Back to top